Malignant neoplasm of stomach, unspecified site 2015 Billable Thru Sept 30/2015 Non-Billable On/After Oct 1/2015 ICD-9-CM 151.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 151.9 should only be used for claims with a date of service on or before September 30, 2015.
Full Answer
A primary or metastatic malignant neoplasm involving the stomach Applies To Carcinoma ventriculi Gastric cancer ICD-9-CM Volume 2 Index entries containing back-references to 151.9: Adenocarcinoma (M8140/3) - see also Neoplasm, by site, malignant diffuse type (M8145/3) specified site - see Neoplasm, by site, malignant unspecified site 151.9
Diagnosis Code for Reimbursement Claim: ICD-9-CM 151.9. Code will be replaced by October 2015 and relabeled as ICD-10-CM 151.9. The Short Description Is: Malig neopl stomach NOS. Known As. Gastric cancer is also known as adenocarcinoma of stomach, adenocarcinoma stomach, CA of stomach, CA stomach adenoca, cancer of the stomach, cancer of the stomach …
2013 ICD-9-CM Diagnosis Code 151.9 Malignant neoplasm of stomach, unspecified site Short description: Malig neopl stomach NOS. ICD-9-CM 151.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 151.9 should only be used for claims with a date of service on or before September 30, 2015.
ICD-9-CM 199.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 199.1 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Gastric cancer is also known as adenocarcinoma of stomach, adenocarcinoma stomach, CA of stomach, CA stomach adenoca, cancer of the stomach, cancer of the stomach adenocarcinoma, primary malignant neoplasm of stomach, and stomach cancer. This applies to carcinoma ventriculi and gastric cancer.
Gastric cancer, also known as stomach cancer, is a type of cancer that occurs in the stomach. Symptoms of gastric cancer are severe indigestion, stomach pains, unintentional weightloss, persistent vomiting, heartburn, bloating, and fatigue.
ICD-9-CM 153.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 153.9 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Primary adenocarcinoma of colon. Clinical Information. A primary or metastatic malignant neoplasm involving the colon. A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma. Malignant tumor of the colon or rectum.
Cancer of the colon, stage 1. Cancer of the colon, stage 2. Cancer of the colon, stage 3. Cancer of the colon, stage 4. Carcinoma of colon, stage I. Carcinoma of colon, stage II. Carcinoma of colon, stage III. Carcinoma of colon, stage IV. Colon cancer.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C16.9 became effective on October 1, 2021.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
The 2022 edition of ICD-10-CM C08.9 became effective on October 1, 2021.